These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 10868972

  • 1. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: the Hoorn study.
    Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.
    Diabetes; 2000 Mar; 49(3):485-91. PubMed ID: 10868972
    [Abstract] [Full Text] [Related]

  • 2. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk.
    Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.
    Arterioscler Thromb Vasc Biol; 2002 Apr 01; 22(4):593-8. PubMed ID: 11950696
    [Abstract] [Full Text] [Related]

  • 3. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
    Wang AY, Lam CW, Wang M, Woo J, Chan IH, Lui SF, Sanderson JE, Li PK.
    Am J Kidney Dis; 2005 Apr 01; 45(4):715-29. PubMed ID: 15806475
    [Abstract] [Full Text] [Related]

  • 4. von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study.
    Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Yudkin JS, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.
    Arterioscler Thromb Vasc Biol; 1999 Dec 01; 19(12):3071-8. PubMed ID: 10591689
    [Abstract] [Full Text] [Related]

  • 5. Serum homocysteine is weakly associated with von Willebrand factor and soluble vascular cell adhesion molecule 1, but not with C-reactive protein in type 2 diabetic and non-diabetic subjects - The Hoorn Study.
    Becker A, Van Hinsbergh VW, Kostense PJ, Jager A, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD.
    Eur J Clin Invest; 2000 Sep 01; 30(9):763-70. PubMed ID: 10998075
    [Abstract] [Full Text] [Related]

  • 6. Why is soluble intercellular adhesion molecule-1 related to cardiovascular mortality?
    Becker A, van Hinsbergh VW, Jager A, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD.
    Eur J Clin Invest; 2002 Jan 01; 32(1):1-8. PubMed ID: 11851720
    [Abstract] [Full Text] [Related]

  • 7. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
    Stam F, van Guldener C, Becker A, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.
    J Am Soc Nephrol; 2006 Feb 01; 17(2):537-45. PubMed ID: 16382015
    [Abstract] [Full Text] [Related]

  • 8. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk.
    de Lemos JA, Hennekens CH, Ridker PM.
    J Am Coll Cardiol; 2000 Aug 01; 36(2):423-6. PubMed ID: 10933352
    [Abstract] [Full Text] [Related]

  • 9. Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study.
    Henry RM, Kostense PJ, Bos G, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD.
    Kidney Int; 2002 Oct 01; 62(4):1402-7. PubMed ID: 12234312
    [Abstract] [Full Text] [Related]

  • 10. Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria.
    Lim SC, Caballero AE, Smakowski P, LoGerfo FW, Horton ES, Veves A.
    Diabetes Care; 1999 Nov 01; 22(11):1865-70. PubMed ID: 10546021
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.
    Dong J, Li YJ, Yang ZK, Xu R.
    Perit Dial Int; 2014 Nov 01; 34(7):706-13. PubMed ID: 24584618
    [Abstract] [Full Text] [Related]

  • 12. Prognostic implications of retinopathy and a high plasma von Willebrand factor concentration in type 2 diabetic subjects with microalbuminuria.
    Jager A, van Hinsbergh VW, Kostense PJ, Emeis JJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Stehouwer CD.
    Nephrol Dial Transplant; 2001 Mar 01; 16(3):529-36. PubMed ID: 11239027
    [Abstract] [Full Text] [Related]

  • 13. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.
    Caballero AE, Arora S, Saouaf R, Lim SC, Smakowski P, Park JY, King GL, LoGerfo FW, Horton ES, Veves A.
    Diabetes; 1999 Sep 01; 48(9):1856-62. PubMed ID: 10480619
    [Abstract] [Full Text] [Related]

  • 14. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients.
    Otsuki M, Hashimoto K, Morimoto Y, Kishimoto T, Kasayama S.
    Diabetes; 1997 Dec 01; 46(12):2096-101. PubMed ID: 9392502
    [Abstract] [Full Text] [Related]

  • 15. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.
    Stenvinkel P, Lindholm B, Heimbürger M, Heimbürger O.
    Nephrol Dial Transplant; 2000 Oct 01; 15(10):1624-30. PubMed ID: 11007832
    [Abstract] [Full Text] [Related]

  • 16. Serum homocysteine levels are associated with the development of (micro)albuminuria: the Hoorn study.
    Jager A, Kostense PJ, Nijpels G, Dekker JM, Heine RJ, Bouter LM, Donker AJ, Stehouwer CD.
    Arterioscler Thromb Vasc Biol; 2001 Jan 01; 21(1):74-81. PubMed ID: 11145936
    [Abstract] [Full Text] [Related]

  • 17. Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification.
    Silvestro A, Brevetti G, Schiano V, Scopacasa F, Chiariello M.
    Thromb Haemost; 2005 Mar 01; 93(3):559-63. PubMed ID: 15735810
    [Abstract] [Full Text] [Related]

  • 18. Elevated serum levels of soluble vascular cell adhesion molecule-1 in NIDDM patients with proliferative diabetic retinopathy.
    Yoshizawa M, Nagai Y, Ohsawa K, Ohta M, Yamashita H, Hisada A, Miyamoto I, Miura K, Takamura T, Kobayashi K.
    Diabetes Res Clin Pract; 1998 Oct 01; 42(1):65-70. PubMed ID: 9884035
    [Abstract] [Full Text] [Related]

  • 19. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease.
    Schmidt AM, Crandall J, Hori O, Cao R, Lakatta E.
    Br J Haematol; 1996 Mar 01; 92(3):747-50. PubMed ID: 8616048
    [Abstract] [Full Text] [Related]

  • 20. Plasma asymmetric dimethylarginine (ADMA) concentration is independently associated with carotid intima-media thickness and plasma soluble vascular cell adhesion molecule-1 (sVCAM-1) concentration in patients with mild-to-moderate renal failure.
    Nanayakkara PW, Teerlink T, Stehouwer CD, Allajar D, Spijkerman A, Schalkwijk C, ter Wee PM, van Guldener C.
    Kidney Int; 2005 Nov 01; 68(5):2230-6. PubMed ID: 16221223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.